News About: Distribution
Bill to expand the subject of rebate punishment to importers and exporters
A bill to expand the subject of rebate punishment to pharmaceutical product licensers, importers and exporters was proposed.
Assemblyperson Sung-joo Kim from the New Politics Alliance for Democracy(NPAD) proposed the...
Complete pharmaceutical distribution increased KRW 3 trillion last year
It was observed the size of complete pharmaceutical product distribution dealt in the domestic market exceeded KRW 48.9 trillion facing KRW 50 trillion soon.
The Korea Pharmaceutical Information Service Center(Center...
The number of pharmaceutical wholesalers has increased 1,300 up since 2000
It was observed the number of pharmaceutical wholesalers, which was only 1,000 companies in 2000, was increased by approximately 1,300 in 14 years as recording 2,356 companies last year.
According to the ‘2015 Annual...
Hanmi-KPDA conflict came to an endThe confrontation of Hanmi Pharm and the Korea Pharmaceutical Distribution Association(KPDA), which has a conflict over the expansion of the pharmaceutical company into the phar...
|
Cooperation of Korean, Chinese and Japanese distribution associations to improve distribution margins
People concerned on Korean, Chinese and Japanese pharmaceutical distribution associations will get together to discuss improvements on unjust business activities, such as low distribution costs of multinational pharma...
Multinational pharmaceutical companies are considering to increase distribution cost by pressure of the pharmaceutical distribution industry
It was known that multinational pharmaceutical companies are reviewing a plan to increase distribution cost by pressure of the pharmaceutical distribution industry.
So far, multinational pharmaceutical companies rais...
“It is shocking and painful to watch Yulin Pharm’s bankruptcy and Hanmi Pharm’s KRW 35.7 billion collection”
On the first day of September, as hearing news about bankruptcy of Yulin Pharm and Hanmi Pharm’s collection worth of KRW 35.7 billion, the pharmaceutical industry has expressed shocking, frustration and painfulness.
...
What is the reason why ‘The Sharp,’ a subsidiary company of Daewoong Pharmaceutical, does not have any conflict with the distribution association?
In regards to indirect expansion of some pharmaceutical companies to the pharmaceutical wholesale industry through operation of pharmaceutical e-commerce stores, the distribution filed has claimed strong opposition.
...
The Korea Pharmaceutical Distribution Association declared firm fight against Hanmi Pharm
The Korea Pharmaceutical Distribution Association(KPDA) has started a firm fight, requesting suspension of Hanmi Pharm’s infringement to the pharmaceutical distribution right.
The KPDA(President Chi-yup Hwang) held a...
The Korea Pharmaceutical Distribution Association resumes attacks toward Pfizer and Novartis
The Korea Pharmaceutical Distribution Association(KPDA) will resume attacks towards Pfizer and Novartis providing distribution margins not even meeting the break-even point.
The KPDA is scheduled to held an expanded ...
